Irovel 150 (Irbesartan) in Kenya

Overview

Irovel 150 contains irbesartan, an angiotensin II receptor blocker (ARB) used to treat hypertension (high blood pressure) and diabetic nephropathy (kidney disease in diabetes). It relaxes blood vessels, lowering BP and protecting kidneys by reducing proteinuria. Available as 150mg tablets, it requires prescription and monitoring.

Composition

• Active Ingredient: Irbesartan 150mg per tablet.
• Form: White, oval, film-coated tablets.
• Inactive Ingredients: Microcrystalline cellulose, lactose, croscarmellose sodium, magnesium stearate.

Side Effects

Common

• Dizziness/Lightheadedness: Especially after the first dose.
• Fatigue: Due to BP reduction.
• Hyperkalemia: High potassium (monitor in renal impairment/diabetes).
• Muscle/Joint Pain: Mild and transient.

Serious Risks

• Angioedema: Facial/throat swelling, breathing difficulty (emergency; discontinue immediately).
• Renal Impairment: Worsening kidney function (monitor creatinine).
• Hypotension: Severe BP drop (risk in volume-depleted patients).
• Hepatotoxicity: Rare (elevated liver enzymes).

How to Use

• Dosage:
  • Hypertension: Start 150mg once daily; max 300mg/day if uncontrolled.
  • Diabetic Nephropathy: 300mg once daily (target dose).
• Administration:
  • Take once daily with or without food.
  • Swallow whole; do not crush/chew.
• Monitoring:
  • Blood Pressure: Check every 2–4 weeks until stable.
  • Renal Function: Serum creatinine/eGFR at baseline, then every 3–6 months.
  • Potassium: Monitor if diabetic or on potassium-sparing drugs.
• Precautions:
  • Avoid if: Bilateral renal artery stenosis, pregnancy (teratogenic), hyperkalemia.
  • Drug Interactions:
    • NSAIDs (e.g., ibuprofen): Reduce efficacy and increase renal risk.
    • Potassium Supplements/ACE Inhibitors: Increase hyperkalemia risk.
    • Lithium: Increased lithium toxicity.

Frequently Asked Questions

1. Is Irovel 150 available over-the-counter?
   No – prescription-only by physicians.

2. Does NHIF cover it?
   Partially – covered for hypertension/diabetic nephropathy under chronic illness scheme (co-payment required).

3. Can it be used for heart failure?
   Off-label – sometimes used but not first-line (preferred: ARBs like losartan/candesartan).

4. What if potassium levels rise?
   Stop immediately and consult a doctor; may need potassium-lowering therapy.

5. Are there cheaper alternatives?
   Yes – generic irbesartan (e.g., Irbes) costs KES 800–1,500/month. Losartan (KES 500–1,000/month) is cheaper.

6. Is it safe during pregnancy?
   No – discontinues immediately if pregnancy detected (risk of fetal injury).

7. How long does one pack last?
   30 days (1 tablet/day).

Conclusion

Irovel 150 is a key therapy for hypertension and diabetic kidney disease in Kenya, offering robust BP control and renal protection. While cost-effective (KES 1,500–2,500/month) and partially NHIF-covered, access remains limited to urban centers. Regular renal/potassium monitoring is non-negotiable, especially in diabetic patients with high CKD prevalence. Generics like Irbes provide affordability, but Irovel’s brand reliability ensures consistent quality. For optimal outcomes, combine with lifestyle changes (low-salt diet, exercise) and avoid NSAIDs. In Kenya’s dual burden of hypertension and diabetes, Irovel plays a vital role in reducing cardiovascular/renal complications when used judiciously.